We have identified the membrane-active regions of the hepatitis C virus p7 protein by performing an exhaustive study of membrane rupture, hemifusion, and fusion induced by a p7-derived peptide library on model membranes having different phospholipid compositions. We report the identification in p7 of a highly membranotropic region located at the loop domain of the protein. Here, we have investigated the interaction of a peptide patterned after the p7 loop (peptide p7 L ), studying its binding and interaction with the lipid bilayer, and evaluated the binding-induced structural changes of the peptide and the phospholipids. We show that positively rich p7 L strongly binds to negatively charged phospholipids and it is localized in a shallow position in the bilayer. Furthermore, peptide p7 L exhibits a high tendency to oligomerize in the presence of phospholipids, which could be the driving force for the formation of the active ion channel. Therefore, our findings suggest that the p7 loop could be an attractive candidate for antiviral drug development, because it could be a target for antiviral compounds that may lead to new vaccine strategies.
Hepatitis C virus (HCV)3 is an enveloped positive singlestranded RNA virus included in the genus Hepacivirus that belongs to the Flaviviridae family. HCV is an important public health problem because it is the leading cause of acute and chronic liver disease in humans, including chronic hepatitis, cirrhosis, and hepatocellular carcinoma (1-3). Currently, there are no vaccines to prevent HCV infection and the available therapeutic agents have very limited efficacy against the virus (4). The HCV genome consists of one translational open reading frame encoding a polyprotein precursor of ϳ3010 amino acids in length, including structural and non-structural proteins, which is cleaved by host and viral proteases (Fig. 1A). The HCV genome is widely heterogeneous; replication errors cause a high rate of mutations (5). HCV entry into the host cell is achieved by fusion of viral and cellular membranes, and the morphogenesis and virion budding has been suggested to take place in the endoplasmic reticulum (6). Therefore, the viral region implicated in fusion to and/or budding from the cells must interact with the membrane and should be a conserved sequence. The variability of the HCV proteins gives the virus the ability to escape the host immune surveillance system and notably hampers the development of an efficient vaccine. Thus, finding inhibitors of protein-membrane and protein-protein interactions involved in virus fusion and/or budding could be an alternative and valuable strategy against HCV infection because they could be potential therapeutic agents.Protein p7 gene is located between the structural and the non-structural regions of the HCV polyprotein precursor, specifically between the E2 and NS2 genes. Cleavage of p7 is mediated by the endoplasmic reticulum (ER) signal peptidases of the host cell (7,8). The protein p7 is classified neither as a structural protein nor as non-struc...